Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials

被引:14
|
作者
Melzer, Georg [1 ]
Maiwald, Tim [2 ]
Prokosch, Hans-Ulrich [1 ]
Ganslandt, Thomas [1 ,3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Chair Med Informat, Wetterkreuz 15, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Elect Engn, Inst Elect Engn, Erlangen, Germany
[3] Heidelberg Univ, Mannheim Univ Med, Dept Biomed Informat, Heinrich Lanz Ctr Digital Hlth, Mannheim, Germany
来源
APPLIED CLINICAL INFORMATICS | 2021年 / 12卷 / 01期
关键词
electronic health records and systems; data warehousing and data marts; secondary use; clinical trial; recruitment; PATIENT RECRUITMENT; MEDICAL INFORMATICS; SYSTEMS; ROUTINE; IMPACT; REPRESENTATION; QUALITY; CARE;
D O I
10.1055/s-0040-1721010
中图分类号
R-058 [];
学科分类号
摘要
Background Even though clinical trials are indispensable for medical research, they are frequently impaired by delayed or incomplete patient recruitment, resulting in cost overruns or aborted studies. Study protocols based on real-world data with precisely expressed eligibility criteria and realistic cohort estimations are crucial for successful study execution. The increasing availability of routine clinical data in electronic health records (EHRs) provides the opportunity to also support patient recruitment during the prescreening phase. While solutions for electronic recruitment support have been published, to our knowledge, no method for the prioritization of eligibility criteria in this context has been explored. Methods In the context of the Electronic Health Records for Clinical Research (EHR4CR) project, we examined the eligibility criteria of the KATHERINE trial. Criteria were extracted from the study protocol, deduplicated, and decomposed. A paper chart review and data warehouse query were executed to retrieve clinical data for the resulting set of simplified criteria separately from both sources. Criteria were scored according to disease specificity, data availability, and discriminatory power based on their content and the clinical dataset. Results The study protocol contained 35 eligibility criteria, which after simplification yielded 70 atomic criteria. For a cohort of 106 patients with breast cancer and neoadjuvant treatment, 47.9% of data elements were captured through paper chart review, with the data warehouse query yielding 26.9% of data elements. Score application resulted in a prioritized subset of 17 criteria, which yielded a sensitivity of 1.00 and specificity 0.57 on EHR data (paper charts, 1.00 and 0.80) compared with actual recruitment in the trial. Conclusion It is possible to prioritize clinical trial eligibility criteria based on real-world data to optimize prescreening of patients on a selected subset of relevant and available criteria and reduce implementation efforts for recruitment support. The performance could be further improved by increasing EHR data coverage.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
  • [21] Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data
    Johnson, Lorraine
    Shapiro, Mira
    Needell, Deanna
    Stricker, Raphael B.
    HEALTHCARE, 2025, 13 (01)
  • [22] HOW MANY PATIENTS IN A REAL WORLD GLIOBLASTOMA POPULATION MEET ELIGIBILITY CRITERIA IN CLINICAL TRIALS?
    Skaga, Erlend
    Skretteberg, Marthe Andrea
    Johannesen, Tom Borge
    Brandal, Petter
    Vik-Mo, Einar Osland
    Helseth, Eirik
    Langmoen, Iver Arne
    NEURO-ONCOLOGY, 2019, 21 : 80 - 80
  • [23] Enhancing clinical trials by linking them to real-world data
    NajafZadeh, Mehdi
    Shimamura, Akiko
    Ben McConnochie
    Polewaczyk, Jimmy
    Demirci, Sevtap
    Talwai, Aniketh
    Ahmed, Amir
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 111 - 111
  • [24] Real-World Data: Applications and Relevance to Cancer Clinical Trials
    Gross, Andrew J.
    Pisano, Courtney E.
    Khunsriraksakul, Chachrit
    Spratt, Daniel E.
    Park, Henry S.
    Sun, Yilun
    Wang, Ming
    Zaorsky, Nicholas G.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (04) : 374 - 385
  • [25] Real-World Patient Eligibility for Transcatheter Tricuspid Valve Interventions: Translating Trials to Clinical Practice
    Kolte, Dhaval
    Elmariah, Sammy
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (10) : 1273 - 1274
  • [26] Real-World Eligibility for Clinical Trials in Extensive Stage Small Cell Lung Cancer Patients
    Dehar, N.
    Meem, M.
    Aggarwal, I.
    Hopman, W.
    Gaudreau, P. -O.
    Robinson, A.
    Fung, A. S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
  • [27] A STRATEGY FOR INCREASING CLINICAL TRIAL DIVERSITY USING REAL-WORLD DATA TO INFORM PATIENT SELECTION CRITERIA
    Kargbo, I. M.
    Jin, H.
    Winer-Jones, J.
    VALUE IN HEALTH, 2022, 25 (07) : S607 - S607
  • [28] Mapping Key Clinical Trial Eligibility Criteria (EC) to Real-world Data (RWD): An Example Using KENYOTE-48
    Zheng, D.
    Jemielita, T.
    Ai, L.
    Black, C. M.
    Hair, G. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E39 - E39
  • [29] Real-world data and clinical research: The complement data from randomized trials
    Maisonneuve, Herve
    Babany, Gerard
    PRESSE MEDICALE, 2015, 44 (06): : 586 - 589
  • [30] Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry
    Nguyen, V. N.
    Lindberg, F.
    Dahlstrom, U.
    Lund, L. H.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 963 - 963